2.35
4.91%
0.11
Senti Biosciences Inc stock is traded at $2.35, with a volume of 8,758.
It is up +4.91% in the last 24 hours and up +4.91% over the past month.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
See More
Previous Close:
$2.24
Open:
$2.3
24h Volume:
8,758
Relative Volume:
0.21
Market Cap:
$10.26M
Revenue:
$1.79M
Net Income/Loss:
$-64.45M
P/E Ratio:
-1.4329
EPS:
-1.64
Net Cash Flow:
$-53.32M
1W Performance:
+5.86%
1M Performance:
+4.91%
6M Performance:
-36.49%
1Y Performance:
-20.61%
Senti Biosciences Inc Stock (SNTI) Company Profile
Name
Senti Biosciences Inc
Sector
Industry
Phone
(650) 382-3281
Address
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-07-22 | Initiated | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Stock (SNTI) Latest News
Senti Biosciences, Inc. (NASDAQ:SNTI) Short Interest Update - MarketBeat
Senti Biosciences faces nasdaq delisting over audit rule By Investing.com - Investing.com Australia
Senti Biosciences faces nasdaq delisting over audit rule - Investing.com India
Senti Biosciences (NASDAQ:SNTI) Trading 7.8% HigherHere's Why - MarketBeat
Institutional owners may take dramatic actions as Semler Scientific, Inc.'s (NASDAQ:SMLR) recent 10% drop adds to one-year losses - Simply Wall St
Biotech Soars On Material Transfer Agreement - Invezz
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
Sensata Technologies Holding plc (NYSE:ST) Stake Decreased by Shapiro Capital Management LLC - Defense World
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Critical Analysis: UL Solutions (NYSE:ULS) & NeoGenomics (NASDAQ:NEO) - Defense World
Daiwa Securities Group Inc. Purchases Shares of 545 Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Semler Scientific Inc (SMLR) Shares Gap Down to $24.43 on Sep 18 - GuruFocus.com
SanBio’s Q2 Financials and Regenerative Medicine Push - TipRanks
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com Australia
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Federated Hermes Inc. Raises Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 - MSN
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Senti Biosciences (NASDAQ:SNTI) Trading Up 5.2% - MarketBeat
Biopharma Layoff Tracker 2024: Lykos, Galera, Grail and More Cut Staff - BioSpace
SNTISenti Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - BioSpace
Intel Dumps All Of Its Shares In Arm Holdings, Still Retains Exposure To Astera Labs, Joby Aviation, MariaDB, And Senti Biosciences - Wccftech
Titan Pharmaceuticals (NASDAQ:TTNP) vs. Senti Biosciences (NASDAQ:SNTI) Critical Contrast - Defense World
A Deep Dive into Senti Biosciences Inc. (SNTI) Stock Performance - The InvestChronicle
Financial Health Report: Senti Biosciences Inc. (SNTI)’s Ratios Tell a Tale - The Dwinnex
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - ForexTV.com
Senti Bio announces execution of grant award from CIRM for developing SENTI-202 - TipRanks
Senti Biosciences announces 1-for-10 reverse stock split - Investing.com India
Senti Biosciences announces 1-for-10 reverse stock split By Investing.com - Investing.com Canada
Senti Biosciences Inc. (SNTI)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Senti Biosciences amends equity facility agreement - Investing.com
Senti Bio executes reverse stock split to meet Nasdaq requirements - Investing.com
Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance - Seeking Alpha
Senti Bio Announces Reverse Stock Split - Yahoo Finance
Senti Biosciences (NASDAQ:SNTI) Trading Down 2.1% - Defense World
There is no way Senti Biosciences Inc. (SNTI) can keep these numbers up - SETE News
Examining Senti Biosciences Inc. (SNTI) stock is warranted - US Post News
Daily Market Movement: Senti Biosciences Inc. (SNTI) Sees a -20.51 Decrease, Closing at 0.31 – DWinneX - The Dwinnex
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAutonomix Medical (NASDAQ:AMIX), Absci ... - Benzinga
Views of Wall Street's Leading Experts on Senti Biosciences Inc. – Sete News - SETE News
Senti Biosciences (NASDAQ: SNTI) Stock Skyrockets on $8 Million Grant Award - ABBO News
Actions for Diversifying Your Penny Stocks Portfolio in 2024 - PennyStocks
why Senti Biosciences Inc. [SNTI] is a Good Choice for Investors After New Price Target of $2.00 – The DBT News - The DBT News
Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks - MarketBeat
Senti Biosciences Inc Stock (SNTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):